Literature DB >> 19623213

APOC3 null mutation affects lipoprotein profile APOC3 deficiency: from mice to man.

Marten H Hofker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19623213      PMCID： PMC2987162          DOI： 10.1038/ejhg.2009.126

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  5 in total

Review 1.  Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3.

Authors:  M C Jong; M H Hofker; L M Havekes
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

2.  Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.

Authors:  Philippa J Talmud; Emma Hawe; Steve Martin; Michael Olivier; George J Miller; Edward M Rubin; Len A Pennacchio; Steve E Humphries
Journal:  Hum Mol Genet       Date:  2002-11-15       Impact factor: 6.150

3.  A mouse model with features of familial combined hyperlipidemia.

Authors:  L Masucci-Magoulas; I J Goldberg; C L Bisgaier; H Serajuddin; O L Francone; J L Breslow; A R Tall
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

4.  A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.

Authors:  Toni I Pollin; Coleen M Damcott; Haiqing Shen; Sandra H Ott; John Shelton; Richard B Horenstein; Wendy Post; John C McLenithan; Lawrence F Bielak; Patricia A Peyser; Braxton D Mitchell; Michael Miller; Jeffrey R O'Connell; Alan R Shuldiner
Journal:  Science       Date:  2008-12-12       Impact factor: 47.728

5.  Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia.

Authors:  N Maeda; H Li; D Lee; P Oliver; S H Quarfordt; J Osada
Journal:  J Biol Chem       Date:  1994-09-23       Impact factor: 5.157
  5 in total
  4 in total

1.  Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategies.

Authors:  Sadik H Kassim; James M Wilson; Daniel J Rader
Journal:  Clin Lipidol       Date:  2010-06

2.  Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China.

Authors:  Juan Yu; Jingjing Huang; Yan Liang; Baodong Qin; Su He; Jing Xiao; Huimin Wang; Renqian Zhong
Journal:  Lipids Health Dis       Date:  2011-11-04       Impact factor: 3.876

3.  Transcriptome Analysis of HepG2 Cells Expressing ORF3 from Swine Hepatitis E Virus to Determine the Effects of ORF3 on Host Cells.

Authors:  Kailian Xu; Shiyu Guo; Tianjing Zhao; Huapei Zhu; Hanwei Jiao; Qiaoyun Shi; Feng Pang; Yaying Li; Guohua Li; Dongmei Peng; Xin Nie; Ying Cheng; Kebang Wu; Li Du; Ke Cui; Wenguang Zhang; Fengyang Wang
Journal:  Biomed Res Int       Date:  2016-08-28       Impact factor: 3.411

4.  Assessing association between protein truncating variants and quantitative traits.

Authors:  Manuel A Rivas; Matti Pirinen; Matthew J Neville; Kyle J Gaulton; Loukas Moutsianas; Cecilia M Lindgren; Fredrik Karpe; Mark I McCarthy; Peter Donnelly
Journal:  Bioinformatics       Date:  2013-07-16       Impact factor: 6.937
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.